The activities of CA1, S100A16, annexin A10 (ANXA10), and MUC1 were increased in the LPS treated IBD colonoids compared to the LPS treated tumor enteroids, while the activities of BAAT, long-chain-fatty-acid-CoA ligase 5 (ACSL5), ectonucleotide pyrophosphatase/phosphodiesterase family member 6 (ENPP6) were decreased (Figure 7). Here, ANXA10 is linked to inflammatory bowel disease.